Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics
Merck is playing defense against Summit Therapeutics with a $3.3 billion licensing deal announced Thursday for a cancer drug.
RFK Jr., vaccines, food dyes, fluoride and why ‘Make America Healthy Again' took off
The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why?